Clinical Trial Update: A Double-Blind Study Evaluating Duvelisib in Subjects With Moderate to Severe Rheumatoid Arthritis and an Inadequate Response to Methotrexate Alone [Phase 2]

View source ↗

Summary

Phase 2 double-blind trial evaluating duvelisib in patients with moderate to severe rheumatoid arthritis who have inadequate response to methotrexate, completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Duvelisib (duvelisib)

Snippet

Sponsor: SecuraBio | Conditions: Rheumatoid Arthritis | Phase 2 | Status: COMPLETED